Sorrento Theraputics Inc. filed for bankruptcy protection
By Hwang, Jin-joon | translator Kim, Jung-Ju
23.02.15 06:18:09
°¡³ª´Ù¶ó
0
Cash equivalent assets of 88.7 billion won as of the third quarter of last year. 1.3 trillion in total assets
222 billion worth of lawsuits lost
Subsidiary Scilex has nothing to do with court receivership
¡ã Sorrento Theraputics Inc. researchers are studying candidate materials
Sorrento Theraputics Inc., a U.S. bio company invested by Yuhan Corporation, filed for bankruptcy protection in the Southern Texas Bankruptcy Court. Bankruptcy protection is a system similar to Korean court receivership. Sorrento Theraputics Inc. recently lost a damage suit worth 222 billion won, resulting in a short-term cash liquidity crisis. Its subsidiary Sciplex plans to continue its business regardless of Sorrento Theraputics Inc.'s bankruptcy protection procedures. According to industries on the 14th, Sorrento Theraputics Inc. filed for bankruptcy protection with the bankruptcy court in accordance with Chapter 11 of the U.S. Bankruptcy Act the previous day.Sorrento Theraputics Inc. is a new anti
Hwang, Jin-joon(jin@dailypharm.com)
If you want to see the full article, please JOIN US (click)